Cargando…
Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
SIMPLE SUMMARY: Biliary tract cancers (BTCs), comprising cancers of the bile ducts (cholangiocarcinoma) as well as gallbladder cancers, continue to be challenging to treat. Cancer immunotherapy strategies harness the immune system to help to attack cancer cells. A number of immunotherapy approaches...
Autores principales: | Lo, Justin H., Agarwal, Rajiv, Goff, Laura W., Heumann, Thatcher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340362/ https://www.ncbi.nlm.nih.gov/pubmed/37444422 http://dx.doi.org/10.3390/cancers15133312 |
Ejemplares similares
-
Targeted therapies in advanced biliary tract cancers—a narrative review
por: LaPelusa, Michael, et al.
Publicado: (2023) -
Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022) -
Biliary Tract Cancer: Current Medical Treatment Strategies
por: Oneda, Ester, et al.
Publicado: (2020) -
Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021) -
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)